Toggle navigation
Toggle search

Antiretroviral medications - reverse transcriptase inhibitors

Table of Contents > Depletions > Antiretroviral medications - reverse transcriptase inhibitors     Print

Selected Medications
Depletions
Editorial Note
Supporting Research

Selected Medications

Reverse transcriptase inhibitors include:

  • Ribavirin (Copegus and Rebetol)
  • Entecavir (Baraclude)
  • Adefovir (Hepsera)
  • Tenofovir(Viread)
  • Abacavir(Ziagen)
  • Emtricitabine(Emtriva)
  • Zidovudine (Retrovir)
  • Didanosine (Videx)
  • Zalcitabine (Hivid)
  • Stavudine (Zerit)
  • Lamivudine (Epivir)

Depletions

There is no evidence that these medications deplete any nutrients.

Editorial Note

The information presented here covers some of the nutrients that may be affected when you take certain medications. If you have the signs and symptoms listed, it does not always mean you have low levels of these nutrients. Many things affect the level of nutrients, including your:

  • Medical history
  • Diet
  • Lifestyle

As well as how long you have been taking the medication. Please talk with your health care provider. They can best address your health care needs and determine whether you are at risk for low levels of any nutrients.

Supporting Research

Gold Standard Drug Database: Drug Monograph: Abacavir, 2016. www.clinicalkey.com/#!/content/drug_monograph/6-s2.0-2332. Accessed July 19, 2016.

Gold Standard Drug Database: Drug Monograph: Adefovir, 2016. www.clinicalkey.com/#!/content/drug_monograph/6-s2.0-2233. Accessed July 19, 2016.

Gold Standard Drug Database: Drug Monograph: Didanosine, 2016. www.clinicalkey.com/#!/content/drug_monograph/6-s2.0-186. Accessed July 7, 2016.

Gold Standard Drug Database: Drug Monograph: Emitricitabine, 2016. www.clinicalkey.com/#!/content/drug_monograph/6-s2.0-2465. Accessed July 19, 2016.

Gold Standard Drug Database: Drug Monograph: Entecavir, 2016. www.clinicalkey.com/#!/content/drug_monograph/6-s2.0-3427. Accessed July 19, 2016.

Gold Standard Drug Database: Drug Monograph: Lamivudine, 2016. www.clinicalkey.com/#!/content/drug_monograph/6-s2.0-339. Accessed July 7, 2016.

Gold Standard Drug Database: Drug Monograph: Ribavirin, 2016. www.clinicalkey.com/#!/content/drug_monograph/6-s2.0-542. Accessed July 7, 2016.

Gold Standard Drug Database: Drug Monograph: Stavudine, 2016. www.clinicalkey.com/#!/content/drug_monograph/6-s2.0-573. Accessed July 7, 2016.

Gold Standard Drug Database: Drug Monograph: Tenofovir, 2016. www.clinicalkey.com/#!/content/drug_monograph/6-s2.0-2477. Accessed July 19, 2016.

Gold Standard Drug Database: Drug Monograph: Zalcitabine, 2016. www.clinicalkey.com/#!/content/drug_monograph/6-s2.0-652. Accessed July 7, 2016

Gold Standard Drug Database: Drug Monograph: Zidovudine, 2016. www.clinicalkey.com/#!/content/drug_monograph/6-s2.0-653. Accessed July 7, 2016.

Review Date: 9/19/2016
Reviewed By: Steven D. Ehrlich, NMD, Solutions Acupuncture, a private practice specializing in complementary and alternative medicine, Phoenix, AZ. Review provided by VeriMed Healthcare Network. Also reviewed by the A.D.A.M. Editorial team.
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- A.D.A.M., a business unit of Ebix, Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
adam.com

We are physicians, hospitals and communities working together to help you live better.